These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 35091227)
21. Bioinformatics analysis of the s2m mutations within the SARS-CoV-2 Omicron lineages. Frye CJ; Shine M; Makowski JA; Kensinger AH; Cunningham CL; Milback EJ; Evanseck JD; Lackey PE; Mihailescu MR J Med Virol; 2023 Jan; 95(1):e28141. PubMed ID: 36098272 [No Abstract] [Full Text] [Related]
22. T-cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine. Li Y; Wang X; Jin J; Ma Z; Liu Y; Zhang X; Su B J Med Virol; 2022 Aug; 94(8):3998-4004. PubMed ID: 35474581 [TBL] [Abstract][Full Text] [Related]
23. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8 Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637 [TBL] [Abstract][Full Text] [Related]
24. Introduction of ORF3a-Q57H SARS-CoV-2 Variant Causing Fourth Epidemic Wave of COVID-19, Hong Kong, China. Chu DKW; Hui KPY; Gu H; Ko RLW; Krishnan P; Ng DYM; Liu GYZ; Wan CKC; Cheung MC; Ng KC; Nicholls JM; Tsang DNC; Peiris M; Chan MCW; Poon LLM Emerg Infect Dis; 2021 May; 27(5):1492-1495. PubMed ID: 33900193 [TBL] [Abstract][Full Text] [Related]
25. Omicron (B.1.1.529) - variant of concern - molecular profile and epidemiology: a mini review. Kannan S; Shaik Syed Ali P; Sheeza A Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8019-8022. PubMed ID: 34982466 [TBL] [Abstract][Full Text] [Related]
26. Significance of the RBD mutations in the SARS-CoV-2 omicron: from spike opening to antibody escape and cell attachment. Hossen ML; Baral P; Sharma T; Gerstman B; Chapagain P Phys Chem Chem Phys; 2022 Apr; 24(16):9123-9129. PubMed ID: 35395667 [TBL] [Abstract][Full Text] [Related]
27. Surveillance of Rodent Pests for SARS-CoV-2 and Other Coronaviruses, Hong Kong. Miot EF; Worthington BM; Ng KH; de Lataillade LG; Pierce MP; Liao Y; Ko R; Shum MH; Cheung WY; Holmes EC; Leung KS; Zhu H; Poon LL; Peiris MJ; Guan Y; Leung GM; Wu JT; Lam TT Emerg Infect Dis; 2022 Feb; 28(2):467-470. PubMed ID: 35076003 [TBL] [Abstract][Full Text] [Related]
28. Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective. Saxena SK; Kumar S; Ansari S; Paweska JT; Maurya VK; Tripathi AK; Abdel-Moneim AS J Med Virol; 2022 Apr; 94(4):1738-1744. PubMed ID: 34905235 [TBL] [Abstract][Full Text] [Related]
29. Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain. Ye G; Liu B; Li F Nat Commun; 2022 Mar; 13(1):1214. PubMed ID: 35241675 [TBL] [Abstract][Full Text] [Related]
30. Genomic Perspectives on the Emerging SARS-CoV-2 Omicron Variant. Ma W; Yang J; Fu H; Su C; Yu C; Wang Q; de Vasconcelos ATR; Bazykin GA; Bao Y; Li M Genomics Proteomics Bioinformatics; 2022 Feb; 20(1):60-69. PubMed ID: 35033679 [TBL] [Abstract][Full Text] [Related]
31. Detection of SARS-CoV-2 and the L452R spike mutation using reverse transcription loop-mediated isothermal amplification plus bioluminescent assay in real-time (RT-LAMP-BART). Iijima T; Ando S; Kanamori D; Kuroda K; Nomura T; Tisi L; Kilgore PE; Percy N; Kohase H; Hayakawa S; Seki M; Hoshino T PLoS One; 2022; 17(3):e0265748. PubMed ID: 35312732 [TBL] [Abstract][Full Text] [Related]
32. The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum. Lu L; Chu AW; Zhang RR; Chan WM; Ip JD; Tsoi HW; Chen LL; Cai JP; Lung DC; Tam AR; Yau YS; Kwan MY; To WK; Tsang OT; Lee LL; Yi H; Ip TC; Poon RW; Siu GK; Mok BW; Cheng VC; Chan KH; Yuen KY; Hung IF; To KK EBioMedicine; 2021 Sep; 71():103544. PubMed ID: 34419925 [TBL] [Abstract][Full Text] [Related]
33. Quantifying the improvement in confirmation efficiency of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the early phase of the outbreak in Hong Kong in 2020. Ran J; Zhao S; Zhuang Z; Chong MKC; Cai Y; Cao P; Wang K; Lou Y; Wang W; Gao D; Yang L; He D; Wang MH Int J Infect Dis; 2020 Jul; 96():284-287. PubMed ID: 32413609 [TBL] [Abstract][Full Text] [Related]
34. Transformations, Lineage Comparisons, and Analysis of Down-to-Up Protomer States of Variants of the SARS-CoV-2 Prefusion Spike Protein, Including the UK Variant B.1.1.7. Peters MH; Bastidas O; Kokron DS; Henze CE Microbiol Spectr; 2021 Sep; 9(1):e0003021. PubMed ID: 34346753 [TBL] [Abstract][Full Text] [Related]
35. Inferring Incidence of Unreported SARS-CoV-2 Infections Using Seroprevalence of Open Reading Frame 8 Antigen, Hong Kong. Zhao S; Mok CKP; Tang YS; Chen C; Sun Y; Chong KC; Hui DSC Emerg Infect Dis; 2024 Feb; 30(2):325-328. PubMed ID: 38167176 [TBL] [Abstract][Full Text] [Related]
36. Host-cell recognition through Cs-GRP78 is enhanced in the new Omicron variant of SARS-CoV-2, in silico structural point of view. Elfiky AA; Ibrahim IM J Infect; 2022 May; 84(5):722-746. PubMed ID: 35063456 [No Abstract] [Full Text] [Related]
37. In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer. Bharathi M; Sivamaruthi BS; Kesika P; Thangaleela S; Chaiyasut C Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200677 [TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis. Zhang Y; Zhang T; Fang Y; Liu J; Ye Q; Ding L Signal Transduct Target Ther; 2022 Mar; 7(1):76. PubMed ID: 35264568 [No Abstract] [Full Text] [Related]